Ane Beatriz Eguzkitza

The prevalence of inflammatory upper airways diseases is estimated around 20% of the worldwide population. These pathologies damagethe life quality of approximate 1000 millions of people suffering that problem implies a huge economical cost.

Today existing treatments do not offer enough efficacy to successfully fight these diseases. It should be...